Access to NOAC Therapy:

Program Goals

Appropriate Use of Anticoagulants in the Setting of NVAF

Drug Initiation of Dabigatran or Warfarin in Patients With AF (2014)

Influence of Anticoagulant Dosing Orbit AF II Registry

Anticoagulant Adherence

OAC is the Most Effective Medicine for Stroke Prevention

Bleeding Risk With NOACs

Higher Copays Associated With Treatment Abandonment or Delay

Burden and Barriers to Adherence

ARISTOTLE: Apixaban vs Warfarin in AF

Care Delivery: Prevention of Thrombosis

Meds-To-Beds Program

General Approach to NOAC Use in Treatment of AF

Patient Assistance Programs

Methods to Improve Patient Adherence and Empower Patients with AF

Applications for the Clinician

Non-Medical Switching: A Prescription for Disaster

NATF Patient Support Group

Tools to Help Patients Understand the Importance of Treatment in AF

Guidelines on NOAC Use in AF

The Impact of Educational Intervention (IMPACT-AF)

AVERROES Trial: Apixaban vs Aspirin

Warfarin vs Aspirin for Stroke Prevention in AF

Events Leading to Discontinuation of OAC

Concluding Remarks

Abbreviations

Abbreviations (cont)

Abbreviations (cont)

Abbreviations (cont)